Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck animal Health, Business Development & Division Support R&D ($B, legacy disclosure)
Form 10-K MD&A Research and Development
Latest, FY2022
4.10
Period ended Dec 31, 2022
Change on a year earlier
-12.8%
4.70 in FY2021
History
5 years
Since FY2018
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Animal Health, Business Development & Division Support R&D ($B, legacy disclosure) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 4.10 | -12.8% | Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 4.70 | +74.1% | Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 2.70 | +3.8% | Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 2.60 | +13.0% | Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 2.30 | – | Form 10-K (mrk1231201910k.htm, filed 2020-02-26) ↗ |
Cite this data
StockData. (2026). Merck Animal Health, Business Development & Division Support R&D ($B, legacy disclosure), annual FY2018–FY2022 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rd_ah_bd_support_b
See every metric in the Merck KPI table. Data updated Oct 26, 2026.